Why Does the Harvard Endowment Invest Heavily in Private Markets?

[TL;DR]

• Harvard’s $56.9B endowment returned 11.9% in FY2025, beating its 8% long-term benchmark
• $1,000 invested in HMC in 1974 = ~$220,000 today vs. ~$140,000 (S&P 500) and ~$75,000 (60/40)
• 41% sits in Private Equity (Buyout 13%, VC 14%, Growth Venture 10%, Growth Buyout 4%)
• Hedge funds at 31% — 16% uncorrelated strategies — serve as the portfolio’s liquidity ballast
• The real edge: manager selection + secondary market discipline + intergenerational governance

The Shift

Under CEO Narv Narvekar, Harvard Management Company dismantled its in-house trading desks and pivoted to a pure outsourced model — systematically cutting real estate and hard assets to fund an aggressive move into private equity and uncorrelated alternatives. But the October 2025 CEO letter reveals a nuance most observers miss: HMC is now deliberately increasing portfolio risk through greater equity exposure, having determined that the fund had been too conservatively positioned relative to its actual ability to absorb volatility. The endowment is not simply chasing returns — it is recalibrating risk to match Harvard’s unique institutional capacity to hold through turbulence.

The Numbers That Prove It

• $1,000 → ~$220,000 since 1974 in HMC vs. ~$140,000 in S&P 500 and ~$75,000 in a traditional 60/40 portfolio
• $46B+ total distributed to Harvard University since HMC was founded in 1974
• 11.9% return in FY2025; 9.6% annualised over 8 years vs. 8.0% long-term benchmark
• 79% of capital in illiquid or long-duration vehicles
• 41% Private Equity — VC 14%, Buyout 13%, Growth Venture 10%, Growth Buyout 4%
• 31% Hedge Funds — Uncorrelated 16%, Long/Short 9%, Multi-strategy 3%, Credit 3%
• Endowment spending = ~40% of Harvard’s annual operating revenue
• Public equities trimmed to 14% — treated as a beta tool, not a return engine

50 Years of Proof: HMC vs. Everything Else

The most compelling argument for Harvard’s model isn’t a single year’s returns — it’s five decades of compounding. Since HMC’s founding in 1974, a $1,000 investment in the endowment has grown to approximately $220,000. The S&P 500 over the same period delivered roughly $140,000. A traditional 60/40 portfolio — the institutional default for most allocators — produced around $75,000. That’s not a marginal difference. HMC’s model has generated nearly 3x the wealth of conventional balanced investing over a full market cycle spanning oil shocks, the dot-com collapse, the 2008 financial crisis, COVID, and multiple rate regimes. The gap widens precisely because the endowment’s private market positions compound quietly during public market drawdowns rather than marking down with the crowd. In total, HMC has distributed more than $46 billion to the University — not as a byproduct of good investing, but as its explicit mandate. Performance here is not optional; endowment distributions now fund more than one-third of Harvard’s entire annual operating budget.

Source: Harvard Management Company

The Illiquidity Problem Is a Feature, Not a Bug

The standard critique of private-heavy portfolios is the capital trap — money locked away for a decade with no exit. Harvard’s answer is structural: because annual distributions are calibrated at roughly 5% of AUM (benchmarked against ~3% inflation + ~5% spending), the fund never needs to be liquid in aggregate. But the CEO letter adds a critical operational detail: HMC actively uses the secondary market as a portfolio management tool — not as a sign of distress, but as a disciplined mechanism to reallocate away from real estate at moments of strength and continuously refine its private equity composition. Liquidity is engineered, not hoped for.

Where the Money Is Going

Source: Harvard Management Company

3 Risks to Know

• Valuation Lag Effect — FY2025 results were explicitly dampened by having less public than private equity exposure during a strong public market recovery; private books mark slowly in both directions
• Federal Endowment Tax Headwind — Narvekar directly flags rising endowment taxation as a compounding drag on purchasing power, raising the return hurdle needed to sustain Harvard’s academic budget
• Manager Selection Chasm — FY2025 outperformance was driven by discerning manager selection across both public equity and hedge funds; median private market exposure without elite GP access delivers far less

Chief Brand & Investor Relations Officer

Sneha Dadrwal

Frequently Asked Questions

Q: Why has Harvard moved away from public equities?

A: Public index exposure has been commoditised — beta is cheap and widely available. HMC views public equities as a liquidity management tool, not a wealth generation engine. The structural alpha — genuine outperformance above the market — now lives almost entirely in unlisted private markets accessible only to patient, connected capital.

Q: What is the Harvard Formula?

A: It's the intersection of three non-negotiable institutional conditions: permanent capital (no forced selling), access advantage (entry into oversubscribed, top-tier GP funds), and long-duration patience (returns measured over decades, not quarters). Remove any one pillar and the model becomes significantly harder — and riskier — to replicate.

Q: Which private asset class gets the largest allocation?

A: Private Equity and Venture Capital at 41% (~$23.3B) is Harvard's dominant position. This covers growth equity, late-stage buyouts, and early-stage venture — spanning the full private company lifecycle from Series A through pre-IPO.

Q: Has Harvard actually solved the illiquidity problem?

A: For Harvard's specific structure, yes. Because annual distributions to the university are capped at ~5–5.5% of AUM, roughly 94–95% of the fund never needs to be liquid in any given year. That structural certainty allows HMC to commit confidently to 7–12 year lock-up vehicles without operational risk.

Q: What risks should allocators consider before replicating this model?

A: Three primary risks: valuation lags distort real performance in both directions; the denominator effect can force awkward rebalancing during public market drawdowns; and without elite GP relationships, private market exposure delivers median — not top-quartile — returns, which may not justify the illiquidity cost.

Q: Is the Harvard endowment model right for family offices?

A: Only partially, and with caveats. The model works when three things align: the allocator has mapped their genuine short-term cash needs and can honestly commit long-duration capital; they have access to institutional-grade GP networks (not retail private equity products); and they possess the governance discipline to hold through paper losses without strategic pivots. Without all three, a simplified version — moderate private allocation, top-tier fund-of-funds access, public equity core — is more appropriate.

Sources

1. https://www.hmc.harvard.edu/
2. https://www.hmc.harvard.edu/wp-content/uploads/2025/10/FY25_HMC_Annual_Report.pdf